A61K 31/404
Indoles
Official title: Indoles, e.g. pindolol
A61K31/404 (Indoles) appears on 4,977 US grants and 9,251 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,977
- Published applications
- 9,251
- Assignees
- 3,314
- Inventors
- 16,358
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 4 | 0 |
| 1978 | 6 | 0 |
| 1979 | 10 | 0 |
| 1980 | 12 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 5 | 0 |
| 1984 | 7 | 0 |
| 1985 | 5 | 0 |
| 1986 | 2 | 0 |
| 1987 | 9 | 0 |
| 1988 | 11 | 0 |
| 1989 | 7 | 0 |
| 1990 | 15 | 0 |
| 1991 | 12 | 0 |
| 1992 | 11 | 0 |
| 1993 | 20 | 0 |
| 1994 | 12 | 0 |
| 1995 | 21 | 0 |
| 1996 | 44 | 0 |
| 1997 | 87 | 0 |
| 1998 | 69 | 0 |
| 1999 | 89 | 0 |
| 2000 | 84 | 0 |
| 2001 | 88 | 49 |
| 2002 | 118 | 170 |
| 2003 | 83 | 245 |
| 2004 | 84 | 274 |
| 2005 | 58 | 219 |
| 2006 | 105 | 241 |
| 2007 | 65 | 243 |
| 2008 | 68 | 218 |
| 2009 | 63 | 241 |
| 2010 | 77 | 246 |
| 2011 | 83 | 255 |
| 2012 | 94 | 254 |
| 2013 | 150 | 338 |
| 2014 | 197 | 433 |
| 2015 | 231 | 452 |
| 2016 | 246 | 467 |
| 2017 | 285 | 484 |
| 2018 | 301 | 455 |
| 2019 | 321 | 439 |
| 2020 | 279 | 456 |
| 2021 | 252 | 469 |
| 2022 | 274 | 568 |
| 2023 | 244 | 596 |
| 2024 | 253 | 522 |
| 2025 | 226 | 531 |
| 2026 | 175 | 386 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method and apparatus for delivering an API-containing liquid to an edible substrate6 Oct 2026US 12,751,915 B2Transport Authority, Inc.
- Methods for delivery of psychedelic medications by inhalation and systems for performing the methods6 Oct 2026US 12,751,940 B2Cybin IRL Limited
- Methods of treating fibrotic liver diseases or conditions with indeglitazar29 Sep 2026US 12,746,225 B2Pleiogenix Inc.
- Pharmaceutical kits and uses thereof for treating colorectal cancer29 Sep 2026US 12,746,226 B2Anbogen Therapeutics, Inc
- Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations29 Sep 2026US 12,746,268 B2Nymox Corporation
- Method and pharmaceutical composition for treating a sleep disorder8 Oct 2026US 2026/0306442 A1Overseas Pharmaceuticals, Ltd.
- Methods for using bacteria and host/microbiota-derived metabolites for diagnosis and treatment of endometriosis8 Oct 2026US 2026/0306451 A1Baylor College of Medicine
- 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) pharmaceutical compositions8 Oct 2026US 2026/0306452 A1Beckley Psytech Limited
- Formulations containing tryptamine derivatives and uses thereof8 Oct 2026US 2026/0306453 A1Psilera Inc.
- N-n-dimethyltryptamine (dmt) and dmt analog oral transmucosal film compositions, methods of making, and methods of use thereof8 Oct 2026US 2026/0306454 A1
Most cited
By later US patents
- Method of treating androgen independent prostate cancer1,091US 9,040,574 B2Natrogen Therapeutics International, Inc. · 2015
- Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use354US 5,091,171 A1992
- Hemostatic tissue sealants283US 6,162,241 AFocal, Inc. · 2000
- Method for treating infectious respiratory diseases270US 5,290,540 AThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. · 1994
- Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions198US 7,048,906 B2Cedars-Sinai Medical Center · 2006